Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05501392 · ClinicalTrials.gov registry record · NA
South Texas Early Prevention Studies PreK
A NA study, sponsored by University of Texas Rio Grande Valley.
- Completed
- Registry status
- NA
- Development phase
- 1,277
- Enrollment target
NCT05501392: Completed NA study, sponsored by University of Texas Rio Grande Valley.
NCT05501392 is a NA study that has completed, run by University of Texas Rio Grande Valley. The registered enrollment target is 1,277 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05501392, a NA study, has completed, sponsored by University of Texas Rio Grande Valley.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,277 participants
- Enrollment target
Study Summary
The South Texas Early Prevention Study-Prekindergarten (STEPS-PreK4) was a cluster randomized trial (CRT) of preschool children 4 years of age to test the effect of the Bienestar/NEEMA Coordinated School Health Program (BN CSHP) on childhood obesity prevalence prevention.
Primary Outcome
as measured by the number of laps run in the Progressive Anaerobic Capacity Endurance Run (PACER) fitness test
Interventions
- BEHAVIORAL STEPS-PreK
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,277 participants |
| Start Date | 2018-09-28 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
What the finished NCT05501392 record still lists
NCT05501392 is an interventional study that assigns participants to a tested intervention. Its 1,277 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which STEPS-PreK is the first listed.
NCT05501392 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05501392 about?
NCT05501392 is a clinical study titled "South Texas Early Prevention Studies PreK". The South Texas Early Prevention Study-Prekindergarten (STEPS-PreK4) was a cluster randomized trial (CRT) of preschool children 4 years of age to test the effect of the Bienestar/NEEMA Coordinated School Health Program (BN CSHP) on childhood obesity prevalence prevention.
What is the current status of trial NCT05501392?
This trial is currently completed. It is a NA study. The enrollment target is 1,277 participants. The study started on 2018-09-28. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT05501392?
The interventions under investigation include: STEPS-PreK (BEHAVIORAL).
Who is sponsoring clinical trial NCT05501392?
This trial is sponsored by University of Texas Rio Grande Valley, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05501392's enrollment target sits among peer trials
1,277 78th of 2000 higher than 1,923 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07001800 · 1,276 participants · Phase 2
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
- NCT07225504 · 1,275 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- NCT06468228 · 1,280 participants · Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI